Next, we sought to prevent cardiomyopathy caused by doxorubicin using GsMTx-4 in an animal model and found blocking TRPC6 in vivo significantly improved cardiac remodeling/fibrosis and dysfunction caused by doxorubicin. The gene discussed is TRPC6; the disease is cardiomyopathy.